Head of Bioavailability & Bioequivalence | 25+ Years Experience | Expert in BA/BE, Regulatory Inspections (USFDA, EMEA), and Global CRO Operations.
M.Sc, MICA | Biopharmaceutical Expert
Strategic Scientific Leader & Operational Expert
I am the Head of Bioavailability & Bioequivalence Department at Vimta Labs Ltd. With over two decades of robust experience in the pharmaceutical and CRO sectors, I am a recognized authority in biopharmaceutical, bioanalytical, and clinical research management.
My expertise spans the entire spectrum of clinical operations—from designing global biopharmaceutics strategies and managing complex regulatory inspections (USFDA, WHO, EMEA, ANVISA) to driving revenue growth and operational efficiency. I have successfully led over 300 client audits and numerous high-stakes regulatory inspections, maintaining a reputation for problem-solving and quality compliance.
Known for mentoring teams and driving innovation, I combine deep scientific knowledge with strategic business acumen, having previously built and scaled full-service CRO operations in India and Canada.
Delivering successful outcomes across Phase I–IV clinical trials
Expert in global biopharmaceutics strategies including ADME, PK/PD modeling, and Biowaivers.
Building and scaling full-service CROs with focus on revenue and EBITDA.
Deep technical expertise in bioanalytical and clinical lab capabilities.
A track record of leadership in global clinical research
Leading overall operations for clinical research facilities, project management, and regulatory functions in Hyderabad.
Devised and deployed processes to boost long-term business success. Monitored strategic level operations and business processes.
Led bioanalytical operations in Ahmedabad, India and Toronto, Canada. Managed cross-functional teams and international compliance.
Responsible for overall operations of BA/BE clinical research facilities and successfully leading numerous regulatory inspections.
Jiwaji University, Gwalior
Jiwaji University, Gwalior
Interested in collaboration or consulting regarding Clinical Research, Bioequivalence, or Regulatory Strategy?